Latest Insider Transactions at Bristol Myers Squibb CO (BMY)
This section provides a real-time view of insider transactions for Bristol Myers Squibb CO (BMY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRISTOL MYERS SQUIBB CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRISTOL MYERS SQUIBB CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,291
-7.47%
|
$132,878
$58.45 P/Share
|
|
Oct 30
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,650
+13.16%
|
-
|
|
Sep 01
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-2.62%
|
$13,200
$60.97 P/Share
|
|
Sep 01
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
642
+7.11%
|
-
|
|
Aug 31
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
39,840
-8.21%
|
$2,470,080
$62.7 P/Share
|
|
Aug 17
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Open market or private sale
|
Direct |
5,327
-67.76%
|
$340,928
$64.0 P/Share
|
|
Aug 13
2020
|
Sandra Leung EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
141,420
-24.63%
|
$8,909,460
$63.24 P/Share
|
|
Aug 01
2020
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,916
-32.11%
|
$1,503,128
$58.66 P/Share
|
|
Aug 01
2020
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,402
+36.51%
|
-
|
|
Jul 01
2020
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-4.52%
|
$21,653
$59.43 P/Share
|
|
Jul 01
2020
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+11.64%
|
-
|
|
Jul 01
2020
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,463
-47.7%
|
$263,317
$59.43 P/Share
|
|
Jul 01
2020
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,356
+50.0%
|
-
|
|
Jun 15
2020
|
Dinesh C Paliwal Director |
BUY
Open market or private purchase
|
Direct |
9,174
+29.33%
|
$495,396
$54.5 P/Share
|
|
Jun 14
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
558
+7.56%
|
-
|
|
Jun 14
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
558
+6.06%
|
-
|
|
Jun 13
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+12.6%
|
-
|
|
Jun 13
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+10.04%
|
-
|
|
Jun 03
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-8.58%
|
$44,280
$60.21 P/Share
|
|
Jun 03
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,154
+20.03%
|
-
|
|
Jun 03
2020
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+35.5%
|
-
|
|
Jun 03
2020
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+29.09%
|
-
|
|
May 22
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
3,200
-16.59%
|
$195,200
$61.01 P/Share
|
|
May 19
2020
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Open market or private sale
|
Direct |
25,000
-48.28%
|
$1,550,000
$62.68 P/Share
|
|
May 01
2020
|
Nadim Ahmed EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,433
-5.22%
|
$85,980
$60.26 P/Share
|
|
May 01
2020
|
Nadim Ahmed EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,908
+9.57%
|
-
|
|
May 01
2020
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
5,274
-8.93%
|
$316,440
$60.26 P/Share
|
|
May 01
2020
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,707
+15.35%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Payment of exercise price or tax liability
|
Direct |
33,321
-5.0%
|
$1,899,297
$57.93 P/Share
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Other acquisition or disposition
|
Direct |
7,075
+1.7%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Exercise of conversion of derivative security
|
Direct |
71,868
+9.42%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Other acquisition or disposition
|
Direct |
397
-0.19%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
BUY
Bona fide gift
|
Indirect |
300,000
+50.0%
|
-
|
|
Mar 10
2020
|
Charles A Bancroft EVP, Head of Integration |
SELL
Bona fide gift
|
Direct |
300,000
-76.47%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,167
-12.62%
|
$693,519
$57.83 P/Share
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
2,497
+3.87%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,426
+18.18%
|
-
|
|
Mar 10
2020
|
Christopher S. Boerner Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
109
-0.44%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
116,943
-4.78%
|
$6,665,751
$57.93 P/Share
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
BUY
Other acquisition or disposition
|
Direct |
20,877
+1.38%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
211,796
+7.71%
|
-
|
|
Mar 10
2020
|
Giovanni Caforio Executive Chair of the Board |
SELL
Other acquisition or disposition
|
Direct |
1,190
-0.15%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,005
-2.14%
|
$114,285
$57.93 P/Share
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Other acquisition or disposition
|
Direct |
561
+0.98%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,007
+4.98%
|
-
|
|
Mar 10
2020
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Other acquisition or disposition
|
Direct |
26
-0.08%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
635
-4.88%
|
$36,195
$57.93 P/Share
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Other acquisition or disposition
|
Direct |
212
+3.0%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
1,571
+10.98%
|
-
|
|
Mar 10
2020
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Other acquisition or disposition
|
Direct |
30
-0.5%
|
-
|